ProQR Therapeutics N.V. Revenue From Contracts With Customers
ProQR Therapeutics N.V. (PRQR) reported Revenue From Contracts With Customers of EUR 15.91 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Income Statement › Other Income
ifrs-full:RevenueFromContractsWithCustomers · last filed 2026-03-12
- ProQR Therapeutics N.V. revenue from contracts with customers for the quarter ending 2025-12-31 was 4.69M EUR, a 8.85% increase year-over-year.
- ProQR Therapeutics N.V. revenue from contracts with customers for the quarter ending 2025-09-30 was 2.88M EUR, a 25.01% decline year-over-year.
- ProQR Therapeutics N.V. revenue from contracts with customers for the quarter ending 2025-06-30 was 3.82M EUR, a 39.46% decline year-over-year.
- ProQR Therapeutics N.V. revenue from contracts with customers for the quarter ending 2025-03-31 was 4.52M EUR, a 1.55% increase year-over-year.
| Period end | Revenue From Contracts With Customers 3 month | Revenue From Contracts With Customers 6 month | Revenue From Contracts With Customers 9 month | Revenue From Contracts With Customers 12 month | Revenue From Contracts With Customers 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | 4.69M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | 7.57M EUR derived: sum of 2 quarters · filed 2026-03-12 | 11.39M EUR derived: sum of 3 quarters · filed 2026-03-12 | 15.91M EUR 20-F · filed 2026-03-12 | |
| 2025-09-30 | 2.88M EUR 6-K · filed 2025-11-06 | 6.70M EUR derived: sum of 2 quarters · filed 2025-11-06 | 11.22M EUR 6-K · filed 2025-11-06 | 15.53M EUR derived: sum of 4 quarters · filed 2026-03-12 | |
| 2025-06-30 | 3.82M EUR 6-K · filed 2025-08-07 | 8.34M EUR 6-K · filed 2025-08-07 | 12.64M EUR derived: sum of 3 quarters · filed 2026-03-12 | 16.49M EUR derived: sum of 4 quarters · filed 2026-03-12 | |
| 2025-03-31 | 4.52M EUR 6-K · filed 2025-05-08 | 8.83M EUR derived: sum of 2 quarters · filed 2026-03-12 | 12.67M EUR derived: sum of 3 quarters · filed 2026-03-12 | 18.97M EUR derived: sum of 4 quarters · filed 2026-03-12 | |
| 2024-12-31 | 4.31M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | 8.15M EUR derived: sum of 2 quarters · filed 2026-03-12 | 14.46M EUR derived: sum of 3 quarters · filed 2026-03-12 | 18.91M EUR 20-F · filed 2026-03-12 | |
| 2024-09-30 | 3.84M EUR 6-K · filed 2025-11-06 | 10.15M EUR derived: sum of 2 quarters · filed 2025-11-06 | 14.60M EUR 6-K · filed 2025-11-06 | 17.88M EUR derived: sum of 4 quarters · filed 2026-03-12 | |
| 2024-06-30 | 6.30M EUR 6-K · filed 2025-08-07 | 10.76M EUR 6-K · filed 2025-08-07 | 14.04M EUR derived: sum of 3 quarters · filed 2026-03-12 | 15.41M EUR derived: sum of 4 quarters · filed 2026-03-12 | |
| 2024-03-31 | 4.45M EUR 6-K · filed 2025-05-08 | 7.73M EUR derived: sum of 2 quarters · filed 2026-03-12 | 9.10M EUR derived: sum of 3 quarters · filed 2026-03-12 | 10.31M EUR derived: sum of 4 quarters · filed 2026-03-12 | |
| 2023-12-31 | 3.28M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | 4.65M EUR derived: sum of 2 quarters · filed 2026-03-12 | 5.86M EUR derived: sum of 3 quarters · filed 2026-03-12 | 6.51M EUR 20-F · filed 2026-03-12 | |
| 2023-09-30 | 1.37M EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | 2.58M EUR derived: sum of 2 quarters · filed 2023-11-07 | 3.23M EUR 6-K · filed 2023-11-07 | 3.95M EUR derived: sum of 4 quarters · filed 2025-03-13 | |
| 2023-06-30 | 1.21M EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-08-03 | 1.86M EUR 6-K · filed 2023-08-03 | 2.58M EUR derived: sum of 3 quarters · filed 2025-03-13 | 3.39M EUR derived: sum of 4 quarters · filed 2025-03-13 | |
| 2023-03-31 | 655.00K EUR 6-K · filed 2023-05-16 | 1.38M EUR derived: sum of 2 quarters · filed 2025-03-13 | 2.19M EUR derived: sum of 3 quarters · filed 2025-03-13 | 3.12M EUR derived: sum of 4 quarters · filed 2025-03-13 | |
| 2022-12-31 | 720.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-03-13 | 1.53M EUR derived: sum of 2 quarters · filed 2025-03-13 | 2.46M EUR derived: sum of 3 quarters · filed 2025-03-13 | 3.59M EUR 20-F · filed 2025-03-13 | 4.04M EUR 20-F · filed 2023-03-29 |
| 2022-09-30 | 814.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | 1.74M EUR derived: sum of 2 quarters · filed 2023-11-07 | 2.87M EUR 6-K · filed 2023-11-07 | ||
| 2022-06-30 | 930.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-08-03 | 2.06M EUR 6-K · filed 2023-08-03 | |||
| 2022-03-31 | 1.13M EUR 6-K · filed 2023-05-16 | ||||
| 2021-12-31 | 1.33M EUR 20-F · filed 2024-03-13 | 1.35M EUR 20-F · filed 2022-04-29 |